ArticleBlood2025

Nanoromidepsin, a polymer nanoparticle of the HDAC inhibitor, improves safety and efficacy in models of T-cell lymphoma.

Ipsita Pal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.